NextFin News - Hong Kong's IPO issuers are rewriting the allocation playbook: with a recovering market and a deeper international book, they now favor long-only and sovereign-wealth investors who will hold, and screen out the flippers who once snapped up cornerstone stakes and sold on day one. After a four-year drought, the comeback has shifted leverage back to sellers — and the scarcest resource in a hot IPO market is no longer capital, it is conviction.
The Comeback That Changed the Balance of Power
For four years, Fidelity International barely touched Hong Kong initial public offerings. Its last meaningful cornerstone commitments dated to 2021, when Chinese short-video platform Kuaishou Technology raised US$5.4 billion and healthcare firm Medlive Technology completed a US$543.4 million listing. Then, late last year, the asset manager came back — backing gold miner Zijin Gold International's US$3.2 billion September 2025 offering, followed by stakes in crypto platform HashKey Group, snack retailer Busy Ming and pork giant Muyuan Foods.
Fidelity is not alone. BlackRock, Temasek and Qatar Investment Authority are reappearing in cornerstone books, and UBS's John Lee, vice-chairman and head of Greater China for global banking, calls it a "robust comeback of international long-only investors – especially European and Middle Eastern sovereign funds." The return spans consumption, industrial and hi-tech sectors, with US and Singapore-based funds also re-emerging as anchor backers.
The timing is not incidental. Hong Kong's IPO market has staged its strongest recovery in years. In the first half of 2026, 87 listings raised a combined HK$210.2 billion (about US$26.9 billion), compared with HK$109.4 billion from 44 raises in the same period of 2025 — a 92 percent jump that made H1 2026 the second-highest first-half volume on record, according to HKEX. EY's mid-year tally put proceeds at HK$209.8 billion across 84 IPOs, a five-year high for the half, and noted that the smallest fundraising among the top ten IPOs exceeded HK$5 billion, versus below HK$2 billion a year earlier. First-day performance has improved alongside size: the proportion of new listings that gained on debut rose from around 70 percent in the first half of 2025 to more than 80 percent in the first half of 2026, according to PwC's mid-year review.
Here is the tension that defines the new market: when capital was scarce, issuers begged for any anchor and accepted whatever shareholder base walked through the door. Now that demand has returned, issuers can afford to be choosy — and they are using that leverage to demand a different kind of shareholder. The question is no longer "who will buy." It is "who will still be holding when the lock-up expires."
The Mechanics: Rules That Make Every Cornerstone Slot Scarce
The playbook rewrite is not only about sentiment; it is mechanical. New rules from the Hong Kong Stock Exchange, adopted in August 2025 and applying to listing documents published on or after 4 August 2025, with further flexibilities for existing issuers taking effect January 1, 2026, require at least 40 percent of an IPO's offer shares to be allocated initially to the bookbuilding placing tranche — the institutional investors who set the final offer price. That ring-fence, reduced from a 50 percent proposal after market feedback, effectively caps the cornerstone tranche at 55 percent of offer shares under the standard clawback mechanism (Mechanism A) and 50 percent under the alternative (Mechanism B).
The exchange also rejected a separate proposal that would have let issuers price up to 10 percent above the top of the indicative range, keeping price discipline in place. For issuers, the combined effect is unmistakable: the cornerstone tranche is now a constrained resource, and every slot in it has to earn its keep. A cornerstone that flips shares into a weak aftermarket no longer just disappoints the underwriter — it burns an allocation the issuer could have given to a holder.
The public subscription side has been loosened in parallel. Under Mechanism A, the retail tranche can start as low as 5 percent and claw back to 15 percent, 25 percent or 35 percent when demand reaches 15, 50 or 100 times the initial allocation respectively. Mechanism B lets issuers start at 10 percent with no clawback, up to a 60 percent maximum. Specialist Technology Companies listed under Chapter 18C face a stricter floor: at least 50 percent of shares must go to the placing tranche, and the 50 percent independent price-setting investor requirement continues to apply.
These changes sit on top of a three-tiered public float regime. Issuers with an expected market value up to HK$6 billion must keep 25 percent in public hands; those between HK$6 billion and HK$30 billion need the higher of a HK$1.5 billion public value or 15 percent; and the largest, above HK$30 billion, need the higher of HK$4.5 billion or 10 percent. Existing issuers can now also adjust their minimum public float after listing if their market capitalization has grown — a flexibility that did not exist before 2026. The definition of "the public" has been tightened too, excluding anyone whose acquisition was financed by the issuer or who is accustomed to taking the issuer's instructions.
The regulatory backdrop reinforces the pressure on deal teams. In December 2025, the Securities and Futures Commission and HKEX sent a joint warning letter to 13 sponsor banks citing specific cases of concern, and in 2026 followed up with on-site inspections to ensure firms maintained adequate resources and strict compliance. A cap limits individual principal bankers to no more than five deals at once. Sponsors, in turn, are passing that scrutiny down the chain: they want books built with investors whose identities, funding sources and holding intentions can withstand regulatory review. A flipper with opaque financing is now a compliance risk, not just an aftermarket nuisance.
Why Long-Only Beats the Flip
The economics are straightforward, but the mechanism is often misunderstood. A cornerstone investor signs a lock-up — historically six months, with the exchange consulting on staggered releases — in exchange for a guaranteed allocation at the offer price. In a normal market, that is a fair trade: certainty of access for certainty of holding. The problem arises when the investor's real horizon is the first pop.
Short-term money does the opposite of what an issuer needs in its price-discovery phase. A hedge fund or family office that takes a cornerstone stake and sells into early strength can turn a well-received IPO into a cautionary tale within days. That depresses the aftermarket, poisons the issuer's ability to return to market for a follow-on, and damages the bookrunner's reputation for the next deal. In a market trying to prove its recovery is durable rather than a dead-cat bounce, issuers and sponsors view that as an unacceptable cost.
Long-only and sovereign-wealth capital does the reverse. HKEX's own analysis of the 20 most active international IPO cornerstone investors — excluding those from the Chinese mainland — found that long-only and sovereign wealth funds were especially active, and "they've consistently continued to add positions post-IPO." That post-listing buying is the real prize: it provides a stabilizing bid through the volatile first quarter of trading, when the stock transitions from underwriter-supported to market-driven pricing.
"Long-only and sovereign wealth funds were especially active, and they've consistently continued to add positions post-IPO."
The shift, then, is from allocating to demand to allocating to conviction. Issuers are not merely asking how much an investor wants at the offer price; they are asking how long it will hold, whether it will add on weakness, and whether its presence signals quality to the rest of the book. Allocation questionnaires have tightened, and sponsors are documenting holding intentions as part of the compliance file.
There is also a signaling channel that runs deeper than any single deal. When a marquee long-only name anchors a listing, it certifies the issuer to the broader market — the same way a top-tier sponsor once did. In a city rebuilding its reputation as a listing venue, that certification is worth more than a slightly higher offer price. Issuers are willing to leave money on the table in exchange for a shareholder register that tells a durable story.
The Counter-Thesis: Is Hong Kong Really in a Position to Be Picky?
The strongest argument against the "picky issuer" narrative is that Hong Kong still needs every dollar it can get. The recovery is real but young. International companies raised more than US$5 billion through primary listings in 2025 — the best year for international listings since 2020 — and the number of international companies listed in the city passed 150 as of March 2026. Only seven international companies listed in 2025, after three in 2024. When the pipeline is still rebuilding, turning away committed capital is a luxury few boards can afford. The more plausible read, critics would say, is that issuers are broadening the book, not narrowing it: welcoming sovereign funds and long-onlys back while still taking hedge-fund and family-office money wherever it is offered.
There is force in that view. The 40 percent bookbuilding floor is a floor, not a ceiling on diversity; Mechanism B for the public tranche preserves flexibility for issuers who want a larger retail footprint. And the return of sophisticated short-term capital to cornerstone roles — Millennium Management, Jane Street and M&G Investments all acted as cornerstones in Hong Kong IPOs this year, their first such commitments in at least a decade according to deal data — shows that hedge-style money has not been shut out.
But the counter-thesis confuses access with treatment. Broadening the book and treating every investor as equal are different things. An issuer can accept a hedge fund's order while weighting the allocation toward holders — giving the long-only anchor a larger slice, a more serious price conversation, and a seat at the table the flipper does not get. The playbook has not become exclusive; it has become discriminatory in the economic sense, pricing scarcity into who receives premium treatment. The 40 percent placing-tranche floor guarantees that price-setting investors get a meaningful allocation; it does not guarantee that every dollar in the book is valued equally.
The falsifying signal is concrete and observable: over the next two listing cycles, compare aftermarket performance between cornerstone-led IPOs dominated by long-only books and those led by shorter-term money, measured by day-30 and day-90 returns relative to the Hang Seng Index. If there is no performance gap, the preference is theater — a branding exercise with no economic consequence. If long-heavy books hold up while mixed books fade, the playbook is real, and issuers who ignore it will pay for it in weaker follow-on access.
Second-Order Effects: Pricing, Sponsors, and the Cross-Border Pipeline
The immediate consequence of pickier issuers is better aftermarket stability — that is the first-order effect everyone sees. The second-order effects run further and matter more.
First, pricing discipline tightens. When issuers know their anchor investors will hold, they have less incentive to leave excessive money on the table to guarantee a first-day pop. A stable, long-only book allows pricing closer to true demand rather than pricing for a flip. Over time, that compresses the average first-day pop and shifts returns from the allocation lottery to genuine stock selection — exactly what the exchange's price-discovery reforms were designed to achieve.
Second, sponsor behavior changes. With 13 firms already scolded and principal bankers capped at five concurrent deals, sponsors face a capacity constraint just as the pipeline thickens. A sponsor's value is no longer just distribution; it is curation. The sponsors who build the most stable books will win the mandate, and the ones known for stuffing deals with flippers will find themselves on the wrong side of the next regulatory inspection. That creates a self-reinforcing loop: better sponsors attract better issuers, which attract better investors.
Third, the cross-border pipeline responds. International companies raised more than US$5 billion in primary listings in 2025, with seven deals from Thailand, Kazakhstan, Indonesia, Singapore, the UAE and the US. The sector mix is broadening beyond finance stalwarts and regional spin-offs into biotech, mining and consumer names. A market known for stable, long-term anchor investors is more attractive to a multinational CFO than one known for day-one volatility. The allocation playbook is therefore not just a Hong Kong story — it is a competitive weapon against Singapore, New York and London for the next wave of Asian listings.
Fourth, the domestic investor base is being re-educated. Retail participation remains a feature of the market — June alone saw 20 IPOs, HKEX noted — but the rule changes deliberately reduce the retail tranche's ability to distort pricing. With clawback thresholds at 15, 50 and 100 times, only the most popular deals shift meaningful allocation to retail. The message to smaller investors is blunt: the price is set by institutions, and the retail slice is a participation right, not a price-setting one.
What Comes Next: Three Time Horizons
In the short term, expect allocation vetting to tighten further. Deal teams will ask not just how much an investor wants, but how long it will hold, and sponsors will document those answers as part of the compliance file. Issuers with weak institutional narratives will find that a hot market does not excuse a thin book. As DLA Piper put it in its assessment of the market, "Gone are the days when a biotech label guaranteed funding." That cuts both ways — picky investors forced issuers to improve, and now picky issuers are forcing investors to prove loyalty.
Over the medium term, the winners are issuers with differentiated fundamentals: breakthrough clinical data in biotech, defensible moats in consumer and industrial names, and cross-border stories that play to the city's international investor base. PwC projects full-year 2026 fundraising could reach HK$380 billion, approaching the 2020 peak, and forecasts at least two to three companies raising HK$10 billion each in the second half. If that holds, Hong Kong will have completed a three-year climb from the bottom back to historical highs — and the investors who showed up early will have been rewarded with the allocations that mattered.
Structurally, the shift reinforces Hong Kong's repositioning from a contingency listing venue to a strategic one. That is the deepest layer of the story. For years, companies treated Hong Kong as the market of last resort when other doors closed. The combination of regulatory reform, a deeper international book, and issuers confident enough to screen their investors signals that the city is being assessed on its own merits again.
The base case is that long-only and sovereign-wealth dominance of cornerstone books persists through 2026, with hedge funds and family offices largely confined to the bookbuilding tranche rather than the anchor slots. The upside case is a broadening of quality: as aftermarket performance validates the approach, more international issuers list, and the definition of a "good investor" expands beyond geography to include any holder with a credible track record. The downside case is that a weak second-half market — a sharp drop in the Hang Seng, a China growth scare, or a geopolitical shock — forces issuers back to taking any anchor they can get, and the pickiness proves to have been a fair-weather luxury.
Hong Kong's IPO recovery was built on the return of capital; its durability will be built on the return of conviction. The issuers who understand the difference are the ones rewriting the playbook. The flippers who assumed a comeback meant a free pass are learning that in a seller's market, access is the currency — and holding is the price of admission.
Explore more exclusive insights at nextfin.ai.
